Search for Clinical Trial Results
Lymphopenia - 20 Studies Found
| Status | Study |
| Completed |
Study Name: Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population Condition:
|
| Terminated |
Study Name: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Condition:
|
| Not yet recruiting |
Study Name: Regional Differences in Human Immunodeficiency Virus (HIV) Testing Condition:
Date: 2017-05-17 Interventions: Other: Medical record review Review of medical records of patients diagnosed for the first time as HIV s |
| Completed |
Study Name: Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients Condition:
Date: 2011-02-28 Interventions:
|
| Withdrawn |
Study Name: Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant Condition:
|
| Completed |
Study Name: Natural History Study of GATA2 Deficiency and Related Disorders Condition:
|
| Completed |
Study Name: EGFRvIII CAR T Cells for Newly-Diagnosed GBM Condition: Glioblastoma Date: 2016-01-22 Interventions: Biological: EGFRvIII CAR T cells The name of the drug is CAR gene-modified T cells or abbreviated as EGF |
| Active, not recruiting |
Study Name: Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Condition: Malignant Neoplasms of Brain Date: 2008-03-19 Interventions:
|
| Completed |
Study Name: Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma Condition: Melanoma (Skin) Date: 2004-09-07 Interventions:
|
| Completed |
Study Name: A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma Condition:
Date: 2015-07-02 Interventions: Drug: Fingolimod Oral fingolimod will be given 1 week prior to the initiation of concurrent radiation an |